ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver"

  • 2017 American Transplant Congress

    Chronic Hepatitis E-Genotype 3 Infection in Transplant Recipients: A Single Kidney and Pancreas Transplant Centre Experience.

    A. Kousios,1 R. Charif,1 E. Sanchez,2 S. Khan,3 F. Regan,4 S. Ijaz,5 D. Muir,2 B. Smith,3 R. Tedder,5 D. Taube,1 J. Galliford.1

    1Renal and Transplant Centre, Imperial College NHS Trust, London, United Kingdom; 2Department of Infection and Immunity, Imperial College NHS Trust, London, United Kingdom; 3Department of Hepatology, Imperial College NHS Trust, London, United Kingdom; 4Department of Hematology, Imperial College NHS Trust, London, United Kingdom; 5Blood Borne Virus Unit, Virus Reference Department, MS-Colindale, Public Health England, London, United Kingdom

    Introduction:In the UK, Hepatitis E virus-genotype 3 (HEV3), is endemic and has now become the major cause of enterically transmitted viral hepatitis. Unlike HEV-genotype 1…
  • 2017 American Transplant Congress

    Ornithine Transcarbamylase Deficiency (OTC) in the Donor Liver, the Importance of Ascertaining the Cause of Death in the Brain Dead Donor.

    M. George,1 G. Thomas,1 A. Shun,1 M. Stormon.2

    1Paediatric Surgery and Transplant Surgery, Children's Hospital at Westmead, Sydney, NSW, Australia; 2Paediatric Gastroenterology, Children's Hospital at Westmead, Sydney, NSW, Australia

    The importance of ascertaining the cause of brain death in the donor is vital . We present a case of cadaveric liver donation (seg 2…
  • 2017 American Transplant Congress

    Restrictive Approach to Simultaneous Liver Kidney Transplantation.

    S. Sultan, S. Fitzpatrick, T. Kozlowski, S. Malik, S. Hanish, D. Bruno, M. Weir, W. Hutson, R. Barth, J. LaMattina.

    Surgery, University of Maryland School of Medicine, Baltimore

    Purpose: MELD based allocation and “Share 35” policy implementation has resulted in an overall increased incidence of renal failure at the time of liver transplantation,…
  • 2017 American Transplant Congress

    Liver Retransplantation: The Largest Post MELD Single Center Experience.

    F. Kaldas, I. Korayem, V. Agopian, T. Russell, S. Ebaid, A. Zarrinpar, H. Yersiz, D. Farmer, R. Busuttil.

    Surgery, University of California Los Angeles, Los Angeles, CA

    OBJECTIVE: Analyze post MELD liver retransplantation (Re-OLT) and identify recipient and donor preoperative risk factors associated with poor patient outcomes.BACKGROUND: Re-OLT is a high risk…
  • 2017 American Transplant Congress

    Phenotypic and Functional Assessment of T Cell Alloimmunity After Liver Transplantation.

    T. Taner, M. Hansen, W. Park, M. Stegall.

    Mayo Clinic, Rochester, MN

    In addition to its metabolic functions, the liver is also an immunologically active organ. Liver transplant recipients are often maintained on less immunosuppression when compared…
  • 2017 American Transplant Congress

    Infectious Complications Following Hepatectomy for Pediatric Hepatoblastoma.

    S. Commander, M. Kueht, T.-A. Ha, A. Rana, J. Goss, S. Vasudevan.

    Pediatric Surgery, Baylor College of Medicine, Houston, TX

    Purpose: To examine if patients with hepatoblastoma (HB) treated with both immunosuppression and chemotherapy have different rates of infection post-operatively than those treated with chemotherapy…
  • 2017 American Transplant Congress

    Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.

    S. Kubal,1 R. Mangus,1 J. Fridell,1 B. Ekser,1 R. Saxena,2 N. Rush,2 N. Higgins,4 M. Ghabril,3 M. Lacerda,3 A. Lobashevsky.4

    1Department of Surgery, Division of Transplantation, Indiana University School of Medicine, Indianapolis, IN; 2Department of Pathology, Indiana University School of Medicine, Indianapolis, IN; 3Department of Gastroenterology, Division of Hepatology, Indiana University School of Medicine, Indianapolis, IN; 4Department of Medicine, Immunology/Histocompatibility Laboratory, Indiana University School of Medicine, Indianapolis, IN

    Background: Post transplant course of circulating de novo donor specific antibodies (DSA) remains unknown after liver transplantation (LT).Methods: In a prospective study, sera from 92…
  • 2017 American Transplant Congress

    Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.

    A. Khalil, S. Ganesh, C. Hughes, A. Tevar, J. Hatche, S. Esper, A. Humar.

    Abdominal Transplant, UPMC, Pittsburgh, PA; Department of Surgery, Ain Shams University, Cairo, Egypt

    Background: Enhanced recovery after surgery protocol has proven its efficacy in many surgery fields in controlling pain and promoting early recovery . The implication of…
  • 2017 American Transplant Congress

    AAV8 Delivery of TIMP-1 Prevents Hepatocyte Apoptosis After Liver Ischemia/Reperfusion Injury.

    S. Duarte, P. Matian, M. Miller, R. Busuttil, A. Coito.

    Dumont-UCLA Transplant Center, Los Angeles

    Matrix metalloproteinase-9 (MMP-9) is a key mediator of leukocyte migration across vascular barriers in hepatic ischemia/reperfusion injury (IRI). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is the…
  • 2017 American Transplant Congress

    Disparity in Transplant Referral Patterns Based on Physician Dependent Variables.

    V. Loy, A. Rzepczynski, S. Bello, C. Blackburn, A. Lu.

    Loyola University Medical Center, Maywood, Il

    Introduction: Distance from a liver transplant (LT) center does not affect outcomes; however, rural areas have lower rates of listing and receiving solid organ transplants.…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 50
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences